Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE plus Arsenic Trioxide in HCC
NCT02956772Phase 2Unknown
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Nov 2016
- Primary completion
- Nov 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in hepatocellular carcinoma (HCC), sponsored by Hunan Provincial People's Hospital. Status: unknown.
02
Drugs
arsenic trioxide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02956772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956772.